Home/Filings/4/0001209191-18-002551
4//SEC Filing

Andrews Kurt J. 4

Accession 0001209191-18-002551

CIK 0001178879other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 6:39 PM ET

Size

7.1 KB

Accession

0001209191-18-002551

Insider Transaction Report

Form 4
Period: 2018-01-03
Andrews Kurt J.
SVP, Human Resources
Transactions
  • Award

    Common Stock

    2018-01-03+5,73240,469 total
  • Award

    Stock Options (right to buy)

    2018-01-03+8,2848,284 total
    Exercise: $15.67Exp: 2028-01-03Common Stock (8,284 underlying)
Footnotes (1)
  • [F1]These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on January 3, 2019. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on February 1, 2019, with the final installment vesting on January 1, 2022.

Issuer

AMICUS THERAPEUTICS INC

CIK 0001178879

Entity typeother

Related Parties

1
  • filerCIK 0001636133

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 6:39 PM ET
Size
7.1 KB